Global Blood Therapeutics Inc (the company became a subdivision of the company Pfizer Inc (PFE)) (GBT) Event Aug. 08, 2022, 10:56 UTC 39 1 comments (90% Positive) GLOBAL BLOOD THERAPEUTICS, INC. (GBT) Announces Clinical Development Update Comment Full text
Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event Aug. 08, 2022, 10:50 UTC 35 1 comments (30% Negative) Karuna Therapeutics, Inc. (KRTX) Reports Q3 2022 Financial Results Comment Full text
Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA) Event Aug. 08, 2022, 10:45 UTC 37 1 comments (10% Negative) Reata Pharmaceuticals, Inc. (RETA) Reports Q3 2022 Financial Results Comment Full text
Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event Aug. 08, 2022, 10:43 UTC 35 1 comments (70% Positive) Karuna Therapeutics, Inc. (KRTX) Provides Update on reduction for Schizophrenia Trial met primary endpoint Comment Full text
AstraZeneca (AZN) Event Aug. 08, 2022, 10:37 UTC 33 1 comments (90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
HUTCHMED DRC (HCM) Event Aug. 08, 2022, 10:24 UTC 36 1 comments (90% Positive) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K) Comment Full text
Reata Pharmaceuticals Inc. (RETA) Event Aug. 08, 2022, 05:31 UTC 111 0 comments Reata Pharmaceuticals Inc. - Reata Pharmaceuticals Second Quarter 2022 Financial Results and Update on Development Programs Comment Full text
ALX Oncology Inc (ALXO) Event Aug. 08, 2022, 00:00 UTC 56 1 comments (75% Positive) ALX ONCOLOGY HOLDINGS INC (ALXO) Reports 47% Loss Reduction for 2022-06-30 Comment Full text
Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event Aug. 08, 2022, 00:00 UTC 44 1 comments (75% Positive) Karuna Therapeutics, Inc. (KRTX) Reports 47% Loss Reduction for 2022-06-30 Comment Full text
Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA) Event Aug. 08, 2022, 00:00 UTC 56 1 comments (51% Neutral) Reata Pharmaceuticals, Inc. (RETA) Reports Net Loss for 2022-06-30 Comment Full text